Caris Life Sciences Inc’s recent filing unveils that its insider Denton John Russel acquired Company’s shares for reported $0.16 million on Jun 20 ’25. In the deal valued at $21.00 per share,7,500 shares were bought. As a result of this transaction, Denton John Russel now holds 123,591 shares worth roughly $3.85 million.
Then, Brille Brian J bought 30,000 shares, generating $630,000 in total proceeds. Upon buying the shares at $21.00, the insider now owns 162,428 shares.
Wolfe Research initiated its Caris Life Sciences Inc [CAI] rating to an Outperform in a research note published on July 14, 2025; the price target was $32. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. JP Morgan began covering CAI with “an Overweight” recommendation on July 14, 2025. Guggenheim started covering the stock on July 14, 2025. It rated CAI as “a Buy”.
Price Performance Review of CAI
On Tuesday, Caris Life Sciences Inc [NASDAQ:CAI] saw its stock jump 4.14% to $31.18. Over the last five days, the stock has gained 2.63%. Nevertheless, the stocks have risen 11.36% over the past one year.
Levels Of Support And Resistance For CAI Stock
The 24-hour chart illustrates a support level at 29.67, which if violated will result in even more drops to 28.17. On the upside, there is a resistance level at 32.23. A further resistance level may holdings at 33.29.
How much short interest is there in Caris Life Sciences Inc?
A steep rise in short interest was recorded in Caris Life Sciences Inc stocks on 2025-10-15, growing by 1.83 million shares to a total of 3.73 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 1.9 million shares. There was a rise of 49.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 14, 2025 when Evercore ISI began covering the stock and recommended ‘”an Outperform”‘ rating along with a $33 price target.
